SCHEMBL20635535

SCHEMBL20635535

CCS(=O)(=O)c1ccc(C(CO)NC(=O)c2ccc3c(c2)cc(Cc2ccc(Cl)cc2C(F)(F)F)n3CCF)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RORC P51449 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20634735 1.00 RORC (1.00) RORC
SCHEMBL30076004 1.00 RORC (1.00) RORC
SCHEMBL20634736 1.00 RORC (1.00) RORC
SCHEMBL29465608 1.00 RORC (1.00) RORC
SCHEMBL22227717 0.95 RORC (0.91) RORC
SCHEMBL22227718 0.95 RORC (0.91) RORC
SCHEMBL22227727 0.94 RORC (0.89) RORC
SCHEMBL22227726 0.94 RORC (0.89) RORC
SCHEMBL22227710 0.94 RORC (0.88) RORC
SCHEMBL22227709 0.94 RORC (0.88) RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109963836-B Deuterium atom substituted indole carboxamide derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2022-11-22 CN disclosed
CN-113227048-B Crystal form of indole carboxamide derivative and preparation method thereof 江苏恒瑞医药股份有限公司 2022-04-12 CN disclosed
CN-109952298-B Indole carboxamide derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2021-09-03 CN disclosed
CN-113227048-A Crystal form of indole carboxamide derivative and preparation method thereof 江苏恒瑞医药股份有限公司 2021-08-06 CN disclosed
US-20200277278-A1 Deuterium Atom-Substituted Indole Formamide Derivative, Preparation Method Therefor, and Medical Applications Thereof JIANGSU HENGRUI MEDICINE CO., LTD. (CN) 2020-09-03 US disclosed
WO-2020140960-A1 CRYSTAL FORM FOR INDOLE-FORMAMIDE DERIVATIVE AND PREPARATION METHOD FOR CRYSTAL FORM 江苏恒瑞医药股份有限公司 2020-07-09 WO disclosed
EP-3650448-A1 INDOLE-FORMAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE Jiangsu Hengrui Medicine Co., Ltd. (CN) 2020-05-13 EP disclosed
EP-3650448-A1 INDOLE-FORMAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE Jiangsu Hengrui Medicine Co., Ltd. (CN) 2020-05-13 EP disclosed
US-20200131123-A1 INDOLE-FORMAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE JIANGSU HENGRUI MEDICINE CO., LTD. (CN) 2020-04-30 US disclosed
US-20200131123-A1 INDOLE-FORMAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE JIANGSU HENGRUI MEDICINE CO., LTD. (CN) 2020-04-30 US disclosed
WO-2019007382-A1 INDOLE-FORMAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE 江苏恒瑞医药股份有限公司 2019-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200277278-A1 Deuterium Atom-Substituted Indole Formamide Derivative, Preparation Method Therefor, and Medical Applications Thereof RORA, RORB, RORC RORC 3/4885
US-20200131123-A1 INDOLE-FORMAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE TPH1, TPH2, PAH RORC 2084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.